Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY   US02043Q1076

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/24/2014 09/25/2014 09/26/2014 09/29/2014 09/30/2014 Date
79.02(c) 77.5(c) 78.8(c) 78.6(c) 78.28 Last
539 768 599 967 573 044 549 674 500 098 Volume
+2.74% -1.92% +1.68% -0.25% -0.41% Change
More quotes
Company
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which develops novel therapeutics based on RNA interference.It is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases, including... 
Sector
Biotechnology & Medical Research
Calendar
10/01 | 11:05amPresentation
Surperformance© rating of Alnylam Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALNYLAM PHARMACEUTICALS, I
Duration : Period :
Alnylam Pharmaceuticals, I Technical Analysis Chart | ALNY | US02043Q1076 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 33,6 M
EBIT 2014 -332 M
Net income 2014 -343 M
Finance 2014 737 M
Yield 2014 -
Sales 2015 45,9 M
EBIT 2015 -199 M
Net income 2015 -214 M
Finance 2015 698 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 157x
EV / Sales 2015 116x
Capitalization 6 001 M
More Financials
Latest news on ALNYLAM PHARMACEUTICALS, I
1d ago ALNYLAM PHARMACEUTICALS : Commences Discovery Trial
4d ago ALNYLAM PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders (f..
6d ago ALNYLAM PHARMACEUTICALS : Presents New Pre-Clinical Data with ALN-CC5, a Subcuta..
6d ago ALNYLAM PHARMACEUTICALS : Broadens Pipeline with ALN-AGT, a Subcutaneously Admin..
6d ago Alnylam Strengthens Management Team with New Key Appointments
6d ago ALNYLAM PHARMACEUTICALS : to Webcast Presentation at Leerink Partners Rare Disea..
6d ago ALNYLAM PHARMACEUTICALS : Initiates DISCOVERY, a Screening Study Examining the P..
09/19 ALNYLAM PHARMACEUTICALS : to Webcast Presentation at 21st Annual NewsMakers in t..
09/18 ALNYLAM PHARMACEUTICALS : Scholar Rock Expands Its Scientific Advisory Board
09/17 ALNYLAM PHARMACEUTICALS : Bolsters Pipeline with ALN-AGT for the Treatment of Hy..
09/16 ALNYLAM PHARMACEUTICALS : Scholar Rock Announces Appointment of Leading Clinicia..
09/16 ALNYLAM PHARMACEUTICALS : Presents New Pre-Clinical Data with ALN-CC5, a Subcuta..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF